CRBP logo

Corbus Pharmaceuticals Holdings (CRBP) Accounts Payable

Annual Accounts Payable

$3.18 M
+$1.00 M+46.21%

31 December 2023

CRBP Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$2.89 M
+$1.74 M+150.61%

30 September 2024

CRBP Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRBP Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+46.2%-38.8%
3 y3 years-56.9%+13.4%
5 y5 years-49.9%-53.4%

CRBP Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-56.9%+78.3%-38.8%+150.6%
5 y5 years-71.3%+78.3%-77.3%+150.6%
alltimeall time-71.3%+1651.2%-77.3%+1490.6%

Corbus Pharmaceuticals Holdings Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$2.89 M(+150.6%)
June 2024
-
$1.15 M(-44.7%)
Mar 2024
-
$2.08 M(-34.5%)
Dec 2023
$3.18 M(+46.2%)
$3.18 M(-32.6%)
Sept 2023
-
$4.71 M(+213.0%)
June 2023
-
$1.51 M(+13.8%)
Mar 2023
-
$1.32 M(-39.1%)
Dec 2022
$2.17 M(+22.0%)
$2.17 M(+58.2%)
Sept 2022
-
$1.37 M(-30.8%)
June 2022
-
$1.99 M(-26.3%)
Mar 2022
-
$2.70 M(+51.3%)
Dec 2021
$1.78 M(-75.9%)
$1.78 M(-30.0%)
Sept 2021
-
$2.55 M(+35.5%)
June 2021
-
$1.88 M(-48.1%)
Mar 2021
-
$3.62 M(-51.0%)
Dec 2020
$7.38 M(-33.5%)
$7.38 M(-33.4%)
Sept 2020
-
$11.08 M(-12.7%)
June 2020
-
$12.70 M(+27.5%)
Mar 2020
-
$9.96 M(-10.2%)
Dec 2019
$11.09 M
$11.09 M(+79.1%)
Sept 2019
-
$6.19 M(-17.3%)
DateAnnualQuarterly
June 2019
-
$7.49 M(-16.4%)
Mar 2019
-
$8.96 M(+41.2%)
Dec 2018
$6.35 M(+102.7%)
$6.35 M(+3.1%)
Sept 2018
-
$6.15 M(+99.7%)
June 2018
-
$3.08 M(-26.1%)
Mar 2018
-
$4.17 M(+33.2%)
Dec 2017
$3.13 M(-8.5%)
$3.13 M(-17.1%)
Sept 2017
-
$3.78 M(-2.2%)
June 2017
-
$3.86 M(+18.2%)
Mar 2017
-
$3.27 M(-4.5%)
Dec 2016
$3.42 M(+160.2%)
$3.42 M(+23.5%)
Sept 2016
-
$2.77 M(+41.1%)
June 2016
-
$1.96 M(+59.5%)
Mar 2016
-
$1.23 M(-6.4%)
Dec 2015
$1.31 M(+281.9%)
$1.31 M(+80.5%)
Sept 2015
-
$728.00 K(-31.9%)
June 2015
-
$1.07 M(+467.8%)
Mar 2015
-
$188.30 K(-45.3%)
Dec 2014
$344.20 K(+89.6%)
$344.20 K(-28.7%)
Sept 2014
-
$482.70 K(+166.0%)
Dec 2013
$181.50 K
$181.50 K

FAQ

  • What is Corbus Pharmaceuticals Holdings annual accounts payable?
  • What is the all time high annual accounts payable for Corbus Pharmaceuticals Holdings?
  • What is Corbus Pharmaceuticals Holdings annual accounts payable year-on-year change?
  • What is Corbus Pharmaceuticals Holdings quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Corbus Pharmaceuticals Holdings?
  • What is Corbus Pharmaceuticals Holdings quarterly accounts payable year-on-year change?

What is Corbus Pharmaceuticals Holdings annual accounts payable?

The current annual accounts payable of CRBP is $3.18 M

What is the all time high annual accounts payable for Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings all-time high annual accounts payable is $11.09 M

What is Corbus Pharmaceuticals Holdings annual accounts payable year-on-year change?

Over the past year, CRBP annual accounts payable has changed by +$1.00 M (+46.21%)

What is Corbus Pharmaceuticals Holdings quarterly accounts payable?

The current quarterly accounts payable of CRBP is $2.89 M

What is the all time high quarterly accounts payable for Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings all-time high quarterly accounts payable is $12.70 M

What is Corbus Pharmaceuticals Holdings quarterly accounts payable year-on-year change?

Over the past year, CRBP quarterly accounts payable has changed by -$1.83 M (-38.75%)